Aanjaneya Lifecare is currently trading at Rs 782.50, up by 10.50 points or 1.36% from its previous closing of Rs 772.00 on the BSE.
The scrip opened at Rs 770.00 and has touched a new high of Rs 799.00 and low of Rs 770.00 respectively. So far 11864 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 799 on 26-Nov-2012 and a 52 week low of Rs 360.85 on 10-May-2012.
Last one week high and low of the scrip stood at Rs 799.00 and Rs 631.00 respectively. The current market cap of the company is Rs 1091.53 crore.
The promoters holding in the company stood at 47.58% while Institutions and Non-Institutions held 0.27% and 52.15% respectively.
Aanjaneya life care has won the Gold Certification award for its Annual Report at the LACP 2012 Global Communications Spotlight Awards Held in Florida USA. LACP Certification is the worlds largest profession’s singular standard for reviewing team-wide communication availability, capability, depth and value. The LACP Vision Awards recognizes the outstanding annual reports of the past twelve months. From Abbott to Zurich Financial, organizations large and small compete against peers of similar size, staff, and means to earn recognition for their organization’s achievements.
Judged across a broad range of criteria, awards are presented across five tiers; platinum, gold, silver, bronze, and honors. Rating is based upon an evaluation point system, which considers a number of factors measuring the effectiveness of communications materials.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: